October 12, 2026
SOHO Insider Hem/Onc Library Community Oncology Shakira Grant on AI impacting pathology and treatment decisions
Community Oncology News

Shakira Grant on AI impacting pathology and treatment decisions

Shakira Grant, MBBS, MSCR, founder and CEO of CROSS Global Research & Strategy, LLC, will present AI Impacting Pathology and Treatment Decisions.

Share This Post:

Leave feedback about this

  • Quality
  • Price
  • Service

PROS

+
Add Field

CONS

+
Add Field

Related Post

FOCUS on DREAMM, Multiple Myeloma, News, Video Interviews

Experts offer advice on treating patients with belantamab mafodotin-based combinations in myeloma

October 7, 2026
China flag
Trending now, Leukemia, Chronic Lymphocytic Leukemia, Lymphoma, Indolent B-Cell Lymphomas, News

China NMPA approves pirtobrutinib in CLL/SLL across all lines of therapy

September 30, 2026
Acute Myeloid Leukemia, MDS News, SOHO 2026, Meetings / Conferences, News, Society Updates, Young Investigator Program

Meet some of the SOHO 2026 Young Investigators

September 28, 2026
FDA laptop
Trending now, Myeloproliferative Neoplasms, News

FDA approves 1st new treatment for essential thrombocythemia in nearly three decades

September 24, 2026
Acute Lymphoblastic Leukemia News, SOHO 2026, Trending now, Meetings / Conferences, News

Dose-dense mini-CVD plus inotuzumab ozogamicin, blinatumomab demonstrates deep, durable responses in relapsed or refractory B-ALL

September 23, 2026
Silver,Spring,,Md,,Usa,-,June,25,,2022:,The,Fda
Myeloproliferative Neoplasms, Primary Myelofibrosis, News

FDA receives sNDA for selinexor, ruxolitinib in myelofibrosis

September 22, 2026